GlassScriptPhysician profile
Lindsey B Johnson
NPI 1275014409
$1,665.56
in general payments reported to CMS, 2019-2025
22 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.20 · 2023: $1,139 · 2024: $328 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,630.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $178.79 | 2023-2024 | Ultomiris |
| Ucb, INC. | $178.30 | 2023-2024 | Briviact, Nayzilam |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.46 | 2025 | Relistor |
| Csl Behring | $150.77 | 2023-2024 | Hizentra |
| Corium, LLC | $132.00 | 2023 | Adlarity |
| Neurocrine Biosciences, INC. | $129.93 | 2023-2024 | Ingrezza, Ongentys |
| Lundbeck LLC | $95.13 | 2023-2024 | Vyepti |
| Neurelis, INC. | $92.19 | 2023-2024 | Valtoco |
| Otsuka America Pharmaceutical, INC. | $89.63 | 2023 | Rexulti, Abilify Asimtufii |
| Lilly USA, LLC | $83.74 | 2023-2024 | Emgality, Amyvid, Reyvow |
| Sk Life Science, INC. | $76.18 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $56.83 | 2023-2024 | |
| Emd Serono, INC. | $48.99 | 2023 | Mavenclad |
| Biogen, INC. | $38.45 | 2023 | Vumerity, Tysabri |
| Amneal Pharmaceuticals LLC | $23.59 | 2024 | Crexont |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Banner Life Sciences, LLC | $23.38 | 2023 | |
| Itamar Medical INC | $22.88 | 2021 | |
| Eisai INC. | $19.43 | 2024 | |
| Pfizer INC. | $17.56 | 2024 | |
| Inspire Medical Systems, INC. | $17.40 | 2023 | Inspire |
| Abbvie INC. | $14.61 | 2024 | |
| Boston Scientific Corporation | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.